BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$156M |
| 2 |
SPDR Gold Trust
GLD
|
+$142M |
| 3 |
Bank of America
BAC
|
+$107M |
| 4 |
iShares MSCI Brazil ETF
EWZ
|
+$92.9M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$81.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.53B |
| 2 |
Equinix
EQIX
|
+$2B |
| 3 |
Gilead Sciences
GILD
|
+$1.63B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1.48B |
| 5 |
United Therapeutics
UTHR
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.44% |
| 2 | Technology | 23.54% |
| 3 | Consumer Discretionary | 8.22% |
| 4 | Materials | 5.85% |
| 5 | Real Estate | 5.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
CALL
KB Home
KBH
$3.42B
| $49K | ﹤0.01% |
+700
| New | +$12K |
|
|
OLP
1927
One Liberty Properties
OLP
$523M
| $49K | ﹤0.01% |
+2,433
| New | +$50.3K |
|
1928
Koppers
KOP
$857M
| $48.9K | ﹤0.01% |
1,068
-4,515
| -81% | -$205K |
|
|
DST
1929
DELISTED
DST Systems Inc.
DST
| $48.8K | ﹤0.01% |
+1,076
| New | +$45.7K |
|
|
WOOF
1930
DELISTED
VCA Inc.
WOOF
| $48.5K | ﹤0.01% |
+1,547
| New | +$45.1K |
|
1931
Alnylam Pharmaceuticals
ALNY
$30.4B
| $48.5K | ﹤0.01% |
754
-15,205
| -95% | -$907K |
|
|
FEIC
1932
DELISTED
FEI COMPANY
FEIC
| $48.3K | ﹤0.01% |
541
-10,506
| -95% | -$931K |
|
|
RAD
1933
DELISTED
Rite Aid Corporation
RAD
| $48K | ﹤0.01% |
474
-9,634
| -95% | -$1.02M |
|
1934
CALL
NOV
NOV
$7.45B
| $47.9K | ﹤0.01% |
609
-942
| -61% | -$68.5K |
|
1935
PUT
Bath & Body Works
BBWI
$3.76B
| $47.5K | ﹤0.01% |
+3,290
| New | +$164K |
|
|
BOBE
1936
DELISTED
Bob Evans Farms, Inc.
BOBE
| $47.5K | ﹤0.01% |
938
-6,647
| -88% | -$364K |
|
|
CNW
1937
DELISTED
CON-WAY INC.
CNW
| $47.3K | ﹤0.01% |
+1,190
| New | +$49.9K |
|
1938
Murphy USA
MUSA
$10.1B
| $47.2K | ﹤0.01% |
+1,135
| New | +$48.1K |
|
1939
CALL
Southern Copper
SCCO
$165B
| $47K | ﹤0.01% |
+218
| New | +$5.41K |
|
|
UTIW
1940
DELISTED
UTI WORLDWIDE INC
UTIW
| $46.6K | ﹤0.01% |
2,655
-20,960
| -89% | -$330K |
|
|
CAM
1941
CALL
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $46.6K | ﹤0.01% |
+1,112
| New | +$64.1K |
|
1942
Bio-Rad Laboratories Class A
BIO
$9.68B
| $46.5K | ﹤0.01% |
+376
| New | +$45.8K |
|
1943
Hawaiian Electric Industries
HE
$2.06B
| $45.7K | ﹤0.01% |
+1,754
| New | +$45.4K |
|
|
KNL
1944
DELISTED
Knoll, Inc.
KNL
| $45.6K | ﹤0.01% |
2,491
-10,542
| -81% | -$179K |
|
1945
Werner Enterprises
WERN
$2.31B
| $45.6K | ﹤0.01% |
1,844
-10,828
| -85% | -$257K |
|
|
CY
1946
DELISTED
Cypress Semiconductor
CY
| $45K | ﹤0.01% |
4,286
-35,009
| -89% | -$332K |
|
|
RFMD
1947
DELISTED
RF MICRO DEVICES INC
RFMD
| $45K | ﹤0.01% |
8,712
-66,493
| -88% | -$357K |
|
1948
Targa Resources
TRGP
$57.6B
| $44.8K | ﹤0.01% |
508
-8,701
| -94% | -$688K |
|
|
KRA
1949
DELISTED
Kraton Corporation
KRA
| $44.6K | ﹤0.01% |
+1,933
| New | +$41.8K |
|
|
ALU
1950
DELISTED
Alcatel-Lucent
ALU
| $44.4K | ﹤0.01% |
10,101
-1,376,749
| -99% | -$5.41M |
|
Similar funds
BNP Paribas Financial Markets's Q4 2013 Portfolio in Review
As of Q4 2013, BNP Paribas Financial Markets held 4,298 positions worth $137B, down 0.25% from $137B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
BNP Paribas Financial Markets withdrew a net $60.2B in Q4 2013, closing 193 positions and reducing 1,811 holdings. Its most notable exit was Innoviva, an estimated $182M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, BNP Paribas Financial Markets opened a new position in Ambev worth $22.5M.
- BNP Paribas Financial Markets's largest Q4 2013 buy was Ambev: 3,066,560 shares worth $22.5M.
- BNP Paribas Financial Markets added most to Apple in Q4 2013, an estimated $156M increase.
- BNP Paribas Financial Markets's biggest Q4 2013 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.53B.
- BNP Paribas Financial Markets fully exited Innoviva in Q4 2013, selling an estimated $182M.
- BNP Paribas Financial Markets's ten largest holdings make up 38% of its $137B portfolio in Q4 2013.
- BNP Paribas Financial Markets opened 1,712 new positions and closed 193 in Q4 2013.
- BNP Paribas Financial Markets's portfolio value fell 0.25% quarter-over-quarter to $137B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2013, filed 12 Feb 2014.